ProQuest Investments IV, L.P., 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 24,949 shares at $61.31 ($1.5M) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $1.5M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.51 | 16,667 | $1.0M | 66.5% |
| 2 | $60.70 | 49 | $3K | 0.2% |
| 3 | $60.70 | 163 | $10K | 0.7% |
| 4 | $61.31 | 8,070 | $495K | 32.6% |
| Total | $60.77 avg | 24,949 | $1.5M | 100% |
| Filing → |
| EGRX | SELL | 2016-10-04 | $1.5M | — | Filing → |
| EGRX | SELL | 2016-09-23 | $13.2M | — | Filing → |
| EGRX | SELL | 2016-08-25 | $1.8M | — | Filing → |